©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Growth Factor Dependence of Progression through G and S Phases of Adult Rat Hepatocytes in Vitro
EVIDENCE OF A MITOGEN RESTRICTION POINT IN MID-LATE G(1)(*)

(Received for publication, October 11, 1995; and in revised form, February 15, 1996)

Pascal Loyer(§)(¶) Sandrine Cariou (§) Denise Glaise Marc Bilodeau Georges Baffet Christiane Guguen-Guillouzo

From the From INSERM U49, Unité de Recherches Hépatologiques, Hôpital Pontchaillou, 35033 Rennes Cedex, France

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Several hepatocyte mitogens have been identified, but the signals triggering the G(0)/G(1) transition and cell cycle progression of hepatocytes remain unknown. Using hepatocyte primary cultures, we investigated the role of epidermal growth factor/pyruvate during the entry into and progression through the G(1) phase and analyzed the expression of cell cycle markers. We show that the G(0)/G(1) transition occurs during hepatocyte isolation as evidenced by the expression of early genes such as c-fos, c-jun, and c-myc. In culture, hepatocytes progress through G(1) regardless of growth factor stimulation until a restriction point (R point) in mid-late G(1) beyond which they cannot complete the cell cycle without mitogenic stimulation. Changes in cell cycle gene expression were associated with progression in G(1); the cyclin E mRNA level is low early in G(1) but increases at the G(1)/S boundary, while the protein is constantly detected during cell cycle but undergoes a change of electrophoretic mobility in mid-late G(1) after the R point. In addition, a drastic induction of cyclin D1 mRNA and protein, and to a lesser extent of cyclin D2 mRNA, takes place in mitogen-stimulated cells after the R point. In contrast, cyclin D3 mRNA appears early in G(1), remains constant in stimulated cells, but accumulates in unstimulated arrested cells, paralleling the cyclin-dependent kinase 4 mRNA expression. These results characterize the different steps of G(1) phase in hepatocytes.


INTRODUCTION

In the normal liver, hepatocytes can remain for very long periods in a quiescent G(0) state. However, they have the capacity to proliferate after chemical intoxication or partial surgical resection of the liver (Higgins and Anderson, 1931). Following a two-thirds hepatectomy (PHT), (^1)hepatocytes rapidly enter the cell cycle and begin their first round of DNA replication 18-20 h later (Fabrikant, 1968). An active field of research during the last 15 years dealt with the identification of factors able to promote hepatocyte DNA synthesis and to understand this compensatory growth. It has been known for some years that hepatocyte growth factor (HGF) and transforming growth factor-alpha (TGF-alpha) are primary mitogens during liver regeneration after partial hepatectomy or administration of CCl(4) (Mead and Fausto, 1989; Michalopoulos, 1990). Mullhaupt et al.(1994) recently reported a rapid increase of EGF levels in the immediate early phase of liver regeneration. Furthermore, HGF, TGF-alpha, and EGF are well characterized mitogens for hepatocytes in primary culture. However, how the hepatocyte cell cycle is controlled by these external factors remains to be clarified.

It is well established that, in vivo, normal hepatocytes are largely unresponsive to growth factors and become competent only after ``priming'' induced by specific treatments such as partial hepatectomy, necrosis following injury, metabolic stress, or any phenomenon leading to disruption of cell-cell contacts (Etienne et al., 1988; Sawada, 1989; Ikeda et al., 1989) or digestion of the extracellular matrix (Liu et al., 1994). These metabolic events would trigger the G(0)/G(1) transition of hepatocytes in vivo and increase the expression of growth factors, which then induce DNA synthesis. This hypothesis is based on the fact that induction of immediate-early oncogenes such as c-fos or c-jun (Corral et al., 1985; Thompson et al., 1986; Sobczack et al., 1989; Morello et al., 1990), takes place 20-30 min after PHT, while HGF level rises around 2 h post PHT (Lindroos et al., 1991). Previous in vitro studies have also shown that hepatocytes express immediate-early oncogenes during cell isolation and in primary culture, in the absence of mitogens. On the other hand, it was clearly established that these ``primed'' hepatocytes would undergo DNA synthesis only when they are stimulated by growth factors (McGowan, 1986; Sawada 1989). We therefore decided to determine whether unstimulated hepatocytes are blocked at a given point in G(1), and how stimulated hepatocytes modulate their response to different mitogenic signals in terms of DNA synthesis.

The G(1) phase has been divided into subphases (Pledger et al., 1977, 1978; Tushinski and Stanley, 1985) during which external signals must impinge on the machinery that regulates the G(1) to S phase transition. In fibroblasts, Pardee(1992) has also described a point in G(1) at which the cells have acquired growth factor independence. He called it the restriction point or R point. It was located near but not concomitant with the initiation of S phase. However, comparison of the data obtained from different in vitro models clearly emphasizes the notion that there are several different regulatory points in G(1) and that each cell type would be defined by a specific behavior in G(1) characterized by its own check point(s) (Pardee, 1992).

Many attempts have been made to identify the proteins which control the progression of the cell cycle through these G(1) check points. Of the proteins characterized to date, the cyclin-dependent kinases (Cdks) and their cyclin partners play a crucial role in cell cycle regulation (Sherr, 1993). Cyclins bound to Cdc2 or Cdk2 appear to be involved in regulating DNA initiation and/or synthesis (Pagano et al., 1992; Zindy et al., 1992) and G(2)/M transition (Pagano et al., 1992; Sherr, 1993), respectively. The cyclin E-Cdk2 complex is activated at the end of G(1) and is considered to be a limiting step at the G(1)/S boundary (Koff et al., 1991; Dulic et al., 1992; Sherr, 1993). The D type cyclins also play a crucial role in G(1) via their association with Cdk2, Cdk4, and Cdk6 (Xiong et al., 1992; Baldin et al., 1993; Quelle et al., 1993; Meyerson and Harlow, 1994). The sequential activation of these complexes and their substrate specificities could be the key to their regulatory function throughout the G(1) phase (Ajchenbaum et al., 1993; Sherr, 1993).

Analysis of the expression and activation of Cdc2 and Cdk2 in regenerating liver revealed that Cdc2 was expressed and active in S, G(2), and M phases but not in G(1), whereas Cdk2 was constantly expressed during the cell cycle but inactive in G(1) (Loyer et al., 1994). The expression and role of the different cyclins and their corresponding Cdk partners in the hepatocyte cell cycle is poorly documented.

In the present report, we used primary cultures of normal rat hepatocytes that were unstimulated or stimulated by EGF to define the different subphases of G(1) and to examine the related expression of various cell cycle markers including proto-oncogenes, cdks, and cyclins.


EXPERIMENTAL PROCEDURES

Antibodies

The anti-p34 is a polyclonal antiserum specifically directed against C-terminal part of human p34 (Pagano et al., 1992). The anti-cyclin E is a rabbit polyclonal antibody directed against the total protein of the Xenopus cyclin E protein (from M. Philippe, Rennes, France). The anti-cyclin D1 is a monoclonal antibody generated against bacterially produced recombinant D1 type cyclin (from C. Sherr, Memphis, TN). For all the Western blot analyses, bands of molecular weights, similar to those found in previous reports using the same antisera, have been obtained.

cDNA Probes

The RNA blots were analyzed with the murine cdc2 cDNA, kindly provided by Dr. P. Nurse (London). Murine cDNAs of cyclins, D1, D2, D3, E, and cdk2 and cdk4 have been provided by Drs. M. Roussel and C. Sherr (Memphis, TN). Human cyclin A cDNA (Wang et al., 1990) was obtained from Dr. C. Bréchot (Paris). Murine cDNAs of c-jun, junB, and junD (Hirai et al. 1989) have been provided by Dr. C. Babinet (Paris). We obtained p53 (Caron de Fromentel et al., 1987) from Dr. P. May (Paris), cDNA of c-myc (Battey et al. 1983) and c-Ki-ras (Chang et al. 1982) from Dr. J. Kruh (Paris). Rat albumin cDNA (Sargent et al., 1979) and 18 S rRNA (human genomic 5.7-kb EcoRI fragment) were used as controls.

Cell Isolation and Culture

Hepatocytes from adult male Sprague-Dawley rats, weighing 180-200 g, were isolated by a two-step collagenase perfusion procedure as described previously (Guguen et al., 1975). Hepatocytes were seeded at 7.5 times 10^4 cells/cm^2 on plastic dishes or 75-cm^2 flasks for total RNA preparation, in a mixture of 75% minimum essential medium and 25% medium 199, supplemented with 10% fetal calf serum, and per ml: 100 IU of penicillin, 100 µg of streptomycin sulfate, 1 mg of bovine serum albumin, and 5 µg of bovine insulin. After cell attachment (4 h later), the medium was renewed with the same medium deprived of fetal calf serum and supplemented with 7 times 10M hydrocortisone hemisuccinate. It was renewed every day thereafter. EGF (Boehringer Mannheim) was used at 50 ng/ml, TGF-alpha (Boehringer Mannheim) at 20 ng/ml, and pyruvate at 20 mM. These growth factors were used in combination with 20 mM of sodium pyruvate, which increases cell attachment and survival and also acts as a comitogen (McGowan, 1986).

[^3H]Methylthymidine Incorporation

DNA replication was estimated by measuring [^3H]methyl-thymidine incorporation. Two µl of [^3H]methylthymidine (ICN, 6.7 Ci/mmol, 1 mCi/ml)/ml of medium (2 µCi/ml final concentration) were incubated for time periods indicated in the legends to the figures. After incubation, medium was removed, and cells were washed, scrapped, and frozen in 1 ml of phosphate-buffered saline. Thereafter, cells were sonicated, and aliquots were taken for protein concentration determination (Bio-Rad method). [^3H]Methylthymidine incorporation was measured after DNA precipitation with 15% trichloroacetic acid, two washes with 10 and 5% trichloroacetic acid successively, and dissolution in formic acid. As others, we have observed a strict correlation between amounts of DNA and protein in this cell system. For convenience, DNA synthesis was estimated as counts/min incorporated/µg of protein.

RNA Extraction and Northern Blot Analysis

The thiocyanate-guanidium procedure was used to extract total RNA (Raymondjean et al., 1983). Twenty µg of total RNA were resolved by electrophoresis in a 1.2% agarose gel, buffered with 10 mM phosphate (pH 7.4) containing 1.1 M formaldehyde, and then transferred onto a nylon sheet (Amersham Corp. Hybond N+) as described by Thomas(1980). Prehybridization was performed according to Andrews et al.(1982). Hybridization with 3 times 10^6 cpm/ml of [alpha-P]dCTP (Amersham, 3000 Ci/mmol) multiprimed DNA probe was carried out for 16 h at 65 °C. Filters were washed with 3 times SSC, 0.1% SDS for 1 h, three times with 1 times SSC, 0.1% SDS and once with 0.1 times SSC, 0.1% SDS at 65 °C for 1 h. Autoradiography was performed for 48 h using an hyperfilm MP (Amersham) with DuPont Lightening Plus intensifying screen at -80 °C.

Preparation of p9-Sepharose Beads

Cdc2 and Cdk2, but not the other Cdks identified so far, bind with a high affinity to a p9 gene product. P9 (p9) was purified from an overproducing strain of Escherichia coli by gel filtration on Sephacryl S200 (Azzi et al., 1992). Fractions containing pure p9 were identified by electrophoresis in 15% polyacrylamide gels and stained with Coomassie Blue. These fractions were used to couple p9 to CNBr-activated Sepharose 4B (Pharmacia Biotech Inc.) according to the instructions of the manufacturer. Unreacted groups on the gel were quenched with 1 M ethanolamine (pH 8). The concentration of coupled p9 was 3 mg/ml of gel. The p9-beads used in this study are strikingly the same as those described by Azzi et al.(1992). These p9-beads are largely used to affinity purify both Cdc2 and Cdk2 from cell extracts. They have been used here for Western blots or measurement of kinase activity of the two Cdks using histone H1 as substrate.

Electrophoresis and Western Blotting

Cdc2-related kinases and cyclin E were purified from cell extracts on p9-beads and recovered with the sample buffer as described previously (Azzi et al. 1992). Cyclin D1 was directly analyzed on crude cell extracts. Then, for all proteins, samples were run on 10% SDS-polyacrylamide gels; proteins were transferred to nitrocellulose paper in a transblot cell (Millipore) for 20 min at 2.5 mA/cm^2 in transfer buffer. Subsequently, the filters were blocked with TBS containing 3% bovine serum albumin for 2 h at room temperature. The filters were then incubated overnight, at 4 °C, with the antiserum and washed three times with TBS, 0.1% Nonidet P-40. For Cdc2 Western blot, the filter was treated with 1 µCi/ml I-labeled protein A (30 Ci/mmol) in TBS, 3% bovine serum albumin, whereas for cyclin D1 and E the filters were incubated with the secondary antibody for 2 h at room temperature. Following three washes in TBS, 0.1% Nonidet P-40, the membranes were either exposed for autoradiography (Cdc2 and cyclin E) or incubated in the presence of nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate substrate for revelation of the alkaline phosphatase activity (cyclin D1).

Histone H1-Kinase Activity Assays

Cdc2 and Cdk2 kinases were purified on p9-beads (Azzi et al. 1992; Loyer et al. 1994). Kinase assays were performed in a mixture containing 10 µl of histone H1 (5 mg/ml, Sigma type IIIS), 5 µl of [-P]ATP (Amersham, 3000 Ci/mmol) and 20 µl of buffer C (Loyer et al. 1994) during 10 min at 30 °C. 5 µl of kinase assay mixtures were loaded on 10% polyacrylamide gels for autoradiographic analysis of the phosphorylated histone H1 after electrophoresis. Gels were dried prior to exposure to hyperfilm MP.


RESULTS

Permanent EGF/Pyruvate Stimulation Induces DNA Synthesis in Most Rat Hepatocytes in Primary Culture

Normal rat hepatocytes were exposed to EGF/pyr just after seeding and all throughout culture. DNA synthesis was assessed by measuring either [^3H]methylthymidine or BrdU incorporation over a 4-day period. In stimulated cultures, no [^3H]methylthymidine incorporation was observed during the first 2 days; DNA replication started after 48 h, reached a maximum at 78 h, and then rapidly decreased (Fig. 1). In control cultures, incorporation was very low. BrdU incorporation analysis revealed that DNA replication occurred in 70-80% of the hepatocytes in EGF/pyr culture conditions between 48 and 120 h (data not shown). These data demonstrated that DNA synthesis was induced in most of the hepatocytes in the presence of EGF/pyr.


Figure 1: Time course of [^3H]methylthymidine incorporation into DNA in unstimulated and EGF/pyr-stimulated primary hepatocyte cultures. Hepatocytes were maintained under unstimulated conditions (box-box) or in the presence of EGF/pyr (-). Cultures were incubated with 2 µCi/ml [^3H]methylthymidine (2-h period) either at seeding or every 8 h for 48 h; and thereafter every 2 h for 94 h. EGF/pyr was added just after cell seeding and every day thereafter with renewal of medium. Cultures were made in duplicate.



Hepatocytes Spontaneously Enter the G(1) Phase during Enzymatic Liver Disruption by Collagenase Perfusion

Using Northern blot analysis, we examined the expression of c-fos, c-jun, and c-myc mRNA levels in hepatocytes during isolation and establishment of primary culture (Fig. 2). mRNA levels of these proto-oncogenes were basically undetectable in normal liver and during Hepes washing. However, levels of both c-fos and c-jun mRNAs rapidly increased during collagenase perfusion, reached a maximum in freshly isolated hepatocytes, and drastically decreased thereafter, while c-myc mRNAs appeared as a faint band in freshly isolated hepatocytes and increased in amount in cultured cells only 4 h after plating.


Figure 2: Levels of c-jun, c-fos, and c-myc mRNAs in hepatocytes during liver dissociation and in primary culture. Total RNAs (20 µg) extracted from normal liver (1), liver after Hepes perfusion (2), or after collagenase perfusion (3); hepatocytes after the first (4) and the second wash in Hepes buffer (5); freshly isolated hepatocytes (6) and hepatocytes 4 h after seeding (7) were analyzed by Northern blot hybridization with cDNA probes for c-jun, c-fos, c-myc, albumin (Alb), and 18 S as a control of the total amounts of RNAs in each lane.



Completion of G(1) Phase and Transition to S Phase Require a Mitogenic Signal

In order to investigate the ability of hepatocytes to progress through G(1), we examined by Northern blot analysis the mRNA levels of the proto-oncogenes, junB, junD, c-myc, and c-Ki-ras, and the p53 anti-oncogene. Their expression was found to be induced in cultured hepatocytes (Fig. 3). A few hours after c-fos, c-jun, junB, junD, and c-myc mRNA levels increased in isolated cells and reached a maximum 6 h after plating. p53 mRNAs were detected 24 h after plating and finally, c-Ki-ras mRNAs at 48 h. This orderly sequence of events allowed us to distinguish the different steps in G(1) phase as immediate-early, early, and mid G(1). These results were compared to the albumin mRNA level which was very high in normal liver and in freshly isolated hepatocytes and greatly decreased in primary culture as previously reported (Guguen-Guillouzo et al., 1983).


Figure 3: Northern blot analysis of proto-oncogene activation in primary culture of rat hepatocytes continuously stimulated by EGF/pyr. Total RNAs (20 µg) extracted from normal liver (biop), freshly isolated hepatocytes (0), and primary hepatocyte cultures at 6, 24, 48, 72, and 96 h, were analyzed by Northern blot hybridization with cDNA probes for c-myc, c-jun, junB, junD, c-Ki-ras, and p53, and albumin (Alb) as control.



We next addressed the question whether the unstimulated as well as the EGF-stimulated cells were able to progress through G(1), by analyzing the mRNA levels of c-myc and p53 which were used as markers of early and mid G(1) respectively. The two cultures expressed c-myc and p53 mRNAs at similar levels and at the same time. However, at day 3, both mRNAs gradually disappeared in EGF-treated cells (Fig. 4A).


Figure 4: A, comparison of c-myc, p53, and cdc2 mRNA levels in unstimulated and stimulated hepatocytes. Each well was loaded with 20 µg of total RNAs isolated from unstimulated (1-4) or EGF/pyr-stimulated (5-8) hepatocytes at 24 (1, 5), 48 (2, 6), 72 (3, 7), and 96 h (4, 8) of culture. After electrophoresis and transfer onto nylon sheet, RNAs were hybridized with c-myc, p53, and cdc2 cDNA probes and 18 S as a control of the total amount of RNAs in each lane. EGF/pyr was added just after seeding and every day thereafter with renewal of medium. B, cdc2 expression in primary cultures of rat hepatocytes stimulated by EGF/pyr. cdc2 expression was investigated at the indicated times in hours, at the mRNA level (cdc2 mRNA) by Northern blot, and protein level (p34) by Western blot, and kinase activity was determined using histone H1 as substrate.



We used Cdc2 and the histone H1 kinase activity associated with p9-beads, as markers to see whether unstimulated and EGF/pyr-stimulated hepatocytes in culture underwent the G(1)/S transition (Fig. 4, A and B). We also analyzed the cdc2 expression at the mRNA level. In the absence of EGF/pyr, cdc2 transcripts were detected as a faint band, if any (Fig. 4A). In contrast, in the continuous presence of EGF/pyr, cdc2 mRNA was detected between 48 and 54 h post plating and was highly expressed at 72 h, while the protein was first detected at 60 h and maximally expressed at 84 h (Fig. 4B). Cdc2 binds to p9 regardless its phosphorylation status or association with cyclins. Therefore, the Cdc2 Western blot after p9 purification represented the real Cdc2 expression in total cell lysates. The kinase activity, measured by the ability of the Cdc2-related proteins (Cdc2 and Cdk2) to phosphorylate histone H1, was detected from 60 h and reached a maximum between 72 and 84 h, correlating mainly with S and M phases as we previously observed in regenerating liver (Loyer et al., 1994).

These results led us to conclude that, under conditions of continuous EGF/pyr stimulation, most hepatocytes reached the G(1)/S boundary approximately 58-60 h after seeding. In contrast, in the absence of mitogenic factor, hepatocytes entered the G(1) phase, progressed up to mid-G(1) but failed to complete the G(1)/S transition.

A Mitogen-associated Restriction Point Is Located in Mid-late G(1)

To determine the point in G(1) beyond which hepatocytes could not progress through without a mitogenic signal, we evaluated the ability of these cells to respond to a 24-h exposure to EGF/pyr, depending on whether this stimulation started immediately, 6, 24, 48, or 72 h after cell plating. For each treatment, DNA synthesis was monitored over 5 days and compared to that in unstimulated cultures (Fig. 5). Three main observations could be made: 1) the total amounts of [^3H]methylthymidine incorporation varied according to the culture conditions. In cultures stimulated during the first 24 h, DNA synthesis was low; it greatly increased in cells stimulated at 24 h, reached a maximal level in cells stimulated at 48 h, but significantly decreased in cells stimulated at 72 h; 2) the peak of thymidine incorporation was either poorly defined in cells stimulated early after seeding (6 h), or maximally abrupt in cells submitted to late stimulation in culture; and 3) cell entry in S phase occurred at approximately 55 to 60 h in hepatocytes stimulated at 6 h (cell spreading) or at 24 h. In contrast, DNA synthesis began only at 68-70 h and 95-98 h in cells exposed to EGF/pyr at 48 and 72 h, respectively.


Figure 5: Effects on hepatocyte DNA synthesis of 24-hr EGF/pyr stimulations performed at different times of culture. Hepatocyte primary cultures were exposed to EGF/pyr during 24 h at different times: cell seeding (A) and 24 (B), 48 (C), and 72 h (D) of culture. [^3H]Methylthymidine incorporation was performed for 2-h periods in the unstimulated (box-box) and EGF/pyr (-)-stimulated cultures and was measured every 2 h during 120 h of culture. Values are expressed as counts/min/µg of protein and are means of triplicate cultures.



These data clearly show that hepatocyte entry in S phase could be delayed by late mitogenic stimulation. The results also suggest that the cells were blocked and arrested at an R point presumably located between 24 and 48 h. In addition, they indicate that hepatocytes remained responsive to EGF/pyr treatment for at least three days of culture. To further define this R point, we performed the following experiment. Hepatocytes were exposed to EGF/pyr for a 12-h period and at different times between 24 and 54 h of culture. [^3H]Methylthymidine incorporation was measured every 6 h from 24 to 84 h of culture (Fig. 6). It appeared that, irrespective of the time of EGF/pyr stimulation prior to 42 h, DNA synthesis always started at 58-60 h of culture. In contrast, later addition of the mitogen, for example at 48 and 54 h, delayed cell entrance in S phase, indicating that the R point was located between 42 and 48 h, in mid-late G(1).


Figure 6: Effects on hepatocyte DNA synthesis of 12-h EGF/pyr stimulations initiated serially in mid and late G(1). EGF/pyr was added to primary cultures at different times: 24 (-), 30 (box-box), 36 (circle-circle), 39 (-), 42 (box- - - - -box), 45 (- - - - -), 48 (up triangle- - - - -up triangle), and 54 (- - - - -) h after seeding. For each condition, [^3H]methylthymidine incorporation was performed for 6-h periods and followed for 30 h. Cultures were made in duplicate. Inset, comparison of DNA synthesis in hepatocyte primary cultures unstimulated or stimulated by EGF/pyr, TGF-alpha/pyr, or FCS/pyr. Hepatocytes were maintained in basal conditions for 48 h, then stimulated during 24 h by EGF/pyr (-), TGF-alpha/pyr (bullet-bullet), or FCS/pyr (-). For each condition, 2 µCi/ml [^3H]methylthymidine were incubated for 8-h periods, and incorporation was measured every 8 h during 104 h; (box-box): unstimulated cultures as control. Cultures were made in duplicate.



In order to address the question whether different growth factors, known to be overproduced during liver regeneration process, were like EGF, capable of overriding the hepatocyte block in mid-late G(1), we compared the DNA synthesis of primary cultures stimulated by EGF/pyr, TGF-alpha/pyr, and FCS/pyr. Four h after seeding, cells were maintained in a mitogenic factor-free medium for two days and then, stimulated by EGF/pyr, TGF-alpha/pyr, or FCS/pyr for a 24 h period. An active DNA replication simultaneously started in the EGF- and TGF-alpha-stimulated cultures approximately 64 h after seeding and displayed similar kinetics, with maximum DNA synthesis occurring 80-88 h post seeding. In contrast, FCS did not significantly induce DNA synthesis (Fig. 6, inset).

Cell DNA Replication in Response to EGF/Pyr Depends on the Length of Stimulation and on the Location of the Cells in the G(1) Phase

To further analyze growth factor dependence of adult hepatocytes in their progression through S phase following EGF/pyr stimulation, we determined the different levels of DNA synthesis obtained in cells exposed to EGF/pyr at 48 h of culture and for increasing time periods from 1 to 42 h. Fig. 7shows that [^3H]methylthymidine incorporation occurred with only 1-h exposure, but the level was very low; then it increased with longer exposures, reached a maximum for the 24-h time period, and remained at the same level upon longer stimulation, at least up to 42 h. This indicated that a 18-24-h period represents the time of EGF/pyr stimulation needed to induce maximal DNA replication.


Figure 7: Hepatocyte DNA replication in response to EGF/pyr pulse stimulations of increasing lengths. Hepatocyte primary cultures were maintained during 48 h in basal conditions and then, stimulated by EGF/pyr for 1, 6, 12, 18, 24, 30, 36, or 42 h (abscissa). [^3H]Methylthymidine incorporation was measured every 6 h up to 90 h. Each point corresponds to the cumulative values of incorporation in counts/min/µg of protein, obtained for each stimulation condition, during the culture period between 48 and 90 h; C, control of basal incorporation, defined as the cumulative values of incorporation, in counts/min/µg of protein, obtained in unstimulated cells during the same culture period (48-90 h). Cultures were made in triplicate.



Differences in the amounts of [^3H]methylthymidine incorporated into the cells were also correlated with the time of culture at which the mitogenic factor was added (see Fig. 5and Fig. 6), suggesting that the hepatocyte response to EGF/pyr could vary during the G(1) phase. Indeed, when EGF/pyr was added for a 24-h period at different times after seeding, the DNA synthesis was low in cultures stimulated just after plating and increased for later stimulations, and the maximal incorporation was observed when stimulation took place at 36 or 42 h, near the R point (data not shown).

These data indicate that the ability of hepatocytes to enter S phase, in response to mitogen, varied according to the length of stimulation and the location of the cells in G(1). This led us to consider the possibility that these variations could be associated with changes in the major cell cycle control proteins which regulate the G(1) progression.

A Drastic Increase of Cyclin D1 Accompanies the R Point Overcrossing in Mid-late G(1)

We examined the expression of different Cdks and cyclins associated with the G(1) phase, in both hepatocytes stimulated by EGF/pyr at 24 h of culture and unstimulated cells (Fig. 8A). Of the Cdk proteins analyzed, the following observations were made: 1) cdc2 mRNAs became detected only at around 54 h (the beginning of S phase) in stimulated cells; 2) cdk2 mRNAs were constantly expressed throughout G(1) independently of the mitogen addition, but there was a gradual increase in mRNA expression from 30 h in mid-G(1), to 60 h in S phase; and 3) cdk4 transcripts were expressed early (18 h) and did not vary significantly in amounts through the G(1) and S phases. Interestingly, only the cdk4 transcripts were much more abundant in unstimulated cells than in their EGF-stimulated counterparts. Of the cyclins analyzed, three different kinetics of expression were found: 1) cyclin A transcripts were barely detectable in both unstimulated and mitogen-treated cells in G(1), but drastically increased between 54 and 60 h in stimulated cells only, a time corresponding to the beginning of S phase; 2) cyclin D3 mRNAs were detected throughout G(1) with an increase in the S and G2 phases, and unexpectedly, accumulated in the absence of mitogen; and 3) cyclin D1 mRNAs appeared as a faint band from early to mid-G(1) but drastically increased in amounts at 42 h in mitogen-stimulated hepatocytes, a time corresponding to the R point, and then remained at high levels for the remaining time course studied. The kinetic of cyclin D2 expression in G(1) resembled that of cyclin D1 with a significant increase at 42 h. Cyclin E mRNAs were detected at a low level during G(1) but their level increased near the G(1)/S boundary, in the presence of mitogen. The transient exposure to FCS during cell attachment had no incidence on the expression pattern of the different proteins studied in both unstimulated and stimulated cultures.


Figure 8: A, Northern blot analysis of the different Cdk and cyclin mRNA levels in unstimulated and EGF/pyr-stimulated hepatocytes during 72 h of culture. Total RNAs (20 µg) were extracted from freshly isolated hepatocytes (0), unstimulated primary cultures (-EGF/pyr) at 18, 24, 36, 48, 60, 66, and 72 h, and stimulated primary cultures (+EGF/pyr) at 27, 30, 36, 42, 48, 60, 66, and 72 h. EGF/pyr was added at 24 h and maintained during culture. RNAs were analyzed by Northern blot hybridization with cdc2, cdk2, cdk4, cyclin A, cyclin E, cyclin D1, D2, and D3 cDNA probes and 18 S as a control of the total amounts of RNAs in each lane. B, Western blot analysis of cyclins D1 and E in primary hepatocyte cultures either unstimulated or stimulated by EGF/pyr at 24 h. a, total proteins at the indicated times were subjected to Western blotting with anti-cyclin D1 antibodies. b, proteins were purified with p9CKShs1-Sepharose beads and subjected to Western blotting with anti-cyclin E antibodies. C+, cyclin E control from p13suc1 Xenopus extracts; C-, bovine serum albumin bound to p13suc1-Sepharose beads; 24*, regenerative rat liver extract at 24 h.



To study the correlation between mRNAs and corresponding proteins we further analyzed the expression of cyclins D1 and E by Western blotting (Fig. 8B). These two cyclins were chosen since their mRNA levels were increased at two different times of G(1) phase, respectively the R point (mid-late G(1)) and the G(1)/S boundary. Cultures were performed following the same protocol as in Fig. 8A. Cyclin D1 was very low in unstimulated cultures. In stimulated cells, it strongly increased at around 60 h and until 96 h, appearing shortly after the induction of the mRNAs. Cyclin E was expressed in both unstimulated and stimulated cultures with very low quantitative variation but displayed a shift in electrophoretic mobility in mitogen-stimulated cells only.

To determine whether induction of cyclin D1 was associated with the ability of the cells to progress in late G(1) after the R point, hepatocytes were exposed to EGF/pyr for a 24-h period as early as 6 h or 24 h after plating, or as late as 48 or 60 h (Fig. 9). These late stimulations resulted in a delayed transition to S phase, as expected by data shown in Fig. 5. The amounts of cyclin D1 mRNAs drastically increased in all conditions, and their location in G(1) and the levels of the peaks of expression varied according to the stimulation: when cells were stimulated at 6 h, the peak was clearly seen at 24-30 h, but at a low rate because of the poor synchrony and the lower number of cells, which progressed up to S phase in these conditions. The maximal expression was observed for exposition to the mitogen at 48 h, a condition corresponding to maximal DNA synthesis. The occurrence of induction was always located after mitogenic stimulation and, therefore, was delayed in cultures lately exposed (at 24, 48, and 60 h) to the mitogen. Interestingly, the time between stimulation and increased cyclin D1 mRNA level was dramatically reduced, for instance from a 24-h to a 6-h period, as this stimulation occurred later in G(1) (Fig. 9, A and D). All of these data clearly showed the association of cyclin D1 induction with progression in late G(1) after the R point. In addition, no induction of cyclin D1 could be observed either after collagenase treatment, cell or tissue washing in Hepes buffer, or cell seeding in culture medium (data not shown).


Figure 9: Modulation of cyclin D1 induction according to the R point overcrossing. Hepatocytes were exposed to EGF/pyr for a 24-h period either early, at 6 (A) and 24 (B) h, or late, at 48 (C) and 60 h (D) of culture. [^3H]Methylthymidine incorporation was measured every 6 h up to 84 h. Total RNAs (10 µg) were extracted from culture samples corresponding, for each condition, to mid and late G(1) and early S phase, and analyzed by Northern blot hybridization with cyclin D1 cDNA probe.




DISCUSSION

In order to understand the molecular and cellular mechanisms involved in liver regeneration and its controls by growth factors, we isolated normal rat hepatocytes and analyzed their cell cycle progression under mitogenic stimulation in an in vitro system. Using this experimental approach, we confirmed that collagenase perfusion of the liver triggers the G(0)/G(1) transition of quiescent normal rat hepatocytes. In addition, we show that cultured hepatocytes were able to progress from early G(1) to a restriction point located in mid-late G(1), regardless of growth factor addition. We demonstrate that this progression in G(1) is essential to make hepatocytes entirely competent to EGF and TGF-alpha signals. We also demonstrate that mitogens do play a crucial role in allowing the cells to override this restriction point and enter the S phase. Furthermore, there was characteristic kinetics of expression of the G(1) cell cycle proteins that were associated with cell cycle progression.

It is generally assumed that division of mammalian cells is mainly controlled during the G(1) phase by signals from the external environment (Pardee, 1992) varying from one cell type to another, defining for each cell type, different characteristic check points. In normal liver, in vivo, hepatocytes are arrested in G(0). One hallmark of the G(0)/G(1) transition is the sequential overexpression of immediate early and early proto-oncogenes such as c-fos, c-jun, c-myc, and p53 (Corral et al., 1985; Thompson et al., 1986; Sobczack et al., 1989; Morello et al., 1990). However, the factors which control this transition remain poorly understood. One hypothesis is that hepatocyte re-entry into G(1) after PHT is a consequence of metabolic changes regardless of growth factors (Corcos et al., 1987; Fausto, 1992). These metabolic changes could be associated with alterations in cell-cell interactions (Etienne et al., 1988). Also the possibility that early activation of a growth factor occurs via a cascade of events related to alteration of the extracellular matrix, cannot be ruled out. Indeed, Liu et al.(1994) have shown that partial degradation of the extracellular matrix of the liver in vivo could also trigger the G(0)/G(1) transition.

It may be argued that normal rat hepatocytes, when seeded in culture, have already entered the early G(1). In this study, we show that they also progress up to mid-late G(1), in the absence of growth factor and serum in the medium. This is consistent with the sequential overexpression of the early G(1) oncogenes c-fos and c-jun during collagenase perfusion, followed by c-myc and junB expression, 4-6 h after seeding, and finally, of c-Ki-ras and p53 expression, after 24 h of culture. In addition, in the absence of mitogen signal, these cells were found to be arrested in mid G(1) and further progression to the G(1)/S boundary was strikingly dependent on growth factor addition. This was supported by the following observations: 1) in the absence of mitogen, cyclins D1 and D2 were low, cyclin A and Cdc2 were not expressed, and DNA synthesis was not observed; and 2) the onset of DNA synthesis was delayed by late addition of EGF on days 2 and 3, and a sharp peak of labeling was observed in these conditions, reflecting the high synchrony of the hepatocyte population arrested at the R point.

From our data, we estimate that the mitogen-dependent R point in rat hepatocytes occurs at the end of the first two-thirds of the G(1) phase, approximately 42-48 h after seeding under our conditions. Considering effects of early and late exposure of hepatocytes to EGF/pyr, the lag time between the R point and the onset of DNA synthesis appears to be approximately 18-20 h. This R point has some similarities with the start point of the yeast G(1)/S transition; in both systems, the R point occurs late in G(1), close to but distinct from the G(1)/S boundary, and both are dependent on external signals (Reed, 1992).

In fibroblasts, G(1) progression requires growth factors (Campisi et al., 1982; Croy and Pardee, 1983), but after the R point, they become growth factor-independent (Yen and Pardee, 1978; Zettenberg and Larsson, 1985). In addition, fibroblasts require at least two factors, platelet-derived growth factor and EGF or insulin-like growth factor, to stimulate the transition of quiescent cells from G(0) to G(1) and from G(1) to S phases, respectively. In contrast, in murine macrophages, one growth factor, the colony-stimulating factor 1, is sufficient to induce transition from quiescence to S phase (Tushinski and Stanley, 1985). Moreover, in this model, colony-stimulating factor 1 must be present throughout G(1) in order to maintain cell cycle progression until S phase. Here we demonstrate that, for cell cycle progression of hepatocytes, growth factor is required in G(1) for awhile, to override the R point. The fact that G(0)/G(1) transition of hepatocytes occurs spontaneously during collagenase perfusion and that G(1)/S transition takes place only after stimulation of the cells by growth factors strongly argues for a dual factor requirement to trigger these two transitions. A first unidentified factor, synthetized and/or secreted or released from the extracellular matrix (Liu et al., 1994) during the tissue disruption, would induce G(0)/G(1) transition but not G(1)/S transition. This last step would require a growth factor acting later in mid-late G(1). Taken together, these results define a specific behavior of hepatocytes regarding the cell cycle progression in G(1) in relation with growth factor stimulation.

It is generally assumed that G(1) cyclins and their corresponding Cdk(s) are integrators of growth factor-mediated signals that drive the cell cycle. However, with the exception of three studies (Lu et al., 1992; Zindy et al., 1992; Albrecht et al., 1995), there is no report describing the kinetic expression of different G(1) proteins in hepatocytes and their association with different steps in G(1) has never been defined in these cells. We confirm the expression of cyclin A and Cdc2 at the S phase entry and showed that cdk2 mRNA is expressed throughout G(1) with an important increase late after growth factor stimulation, whereas the H1 kinase activity was mainly detected in S and M phases. The cyclin E mRNAs were found as a weak band in unstimulated culture and their level greatly increased in late G(1) only after mitogenic stimulation. It may reflect an activation of this cyclin only in cells which have overcrossed the R point. In addition, cyclin E Western blot was performed on p9-Cdk-cyclin affinity purified complexes. Since this protein does not bind p9 directly but via its binding to a Cdk, likely Cdk2 as reported by Koff et al.(1991) and Dulic et al.(1992), we may assume that the kinetic corresponded to the levels of cyclin E complexed with Cdk2 along the cell cycle. We did not find significant variation in the level of cyclin E protein, but interestingly, a change in the electrophoretic mobility, probably related to a modification of its phosphorylation status, was evidenced in mid-late G(1) after mitogenic stimulation. This likely reflects an activation of the complex in cells which have overcrossed the R point.

In contrast, we show that cyclin D1 mRNA levels and protein expression are both greatly increased after mitogenic stimulation. Accumulation of mRNAs correlated with the R point onset, whereas the cyclin D1 protein was detected 10-15 h later. The induction of cyclin D1 mRNAs correlated well with that located in mid-late G(1) in regenerating liver (data not shown). Albrecht et al.(1995) have also reported that cyclin D1 protein was abundantly induced in vitro in HGF stimulated hepatocytes. A similar induction of cyclin D1 has also been reported in macrophages (Matsushime et al., 1991); the peptide could not be immunoprecipitated from colony-stimulating factor-1-starved macrophages blocked in G(1) while it accumulated early after the mitogen addition. However, we do not know whether between cyclin D1 mRNA and protein appearance cells progress in cell cycle or if they are arrested until the protein is expressed.

Interestingly, we observed that this drastic cyclin D1 mRNA activation is dependent on the growth factor stimulation and coincided with hepatocyte progression beyond the R point in response to this stimulation. Thus, if progression beyond the R point was delayed by late mitogen stimulation, cyclin D1 induction was delayed in parallel. This result is in agreement with the hypothesis that cyclin D1 plays a critical role in cell progression in late G(1) after the R point, and contributes to the so-called cell cycle clock (Sherr, 1993) by ensuring the commitment of cells to enter S phase.

In contrast, cyclin D3 appears to accumulate in the absence of mitogen signal, whereas cyclins D1 and D2 are weakly detected, indicating that the three D type cyclins are differentially activated throughout the cell cycle. These D type cyclins have been previously reported to be differentially expressed in various cell lineages, and it has also been suggested that their roles are distinct (Ajchenbaum et al., 1993; Kato and Sherr, 1993; Sherr, 1994). Our results are in agreement with these hypotheses. It is intriguing to note the correlation between the accumulation of cyclin D3, cdk4, and to a lesser extent cdk2 mRNAs, in the absence of mitogen stimulation. The role of these cyclins accumulated in unstimulated cells must be further analyzed.

Altogether, these observations are consistent with the idea that the D-type cyclins may be multifunctional regulators that could target different Cdk partners (Sherr, 1993, 1994). Experiments are now in progress to determine which of these Cdks directly associate with the cyclins to form complexes that serve to link growth factor stimulation with cell cycle progression of hepatocytes and which activators or inhibitors may control this process.


FOOTNOTES

*
This work was supported by l'Institut National de la Santé et de la Recherche Médicale (INSERM) and the European Community (BIOT-CT 900189). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Recipient of a fellowship from l'Association pour la Recherche Contre le Cancer et le Ministère de la Recherche et de l'Espace (MRE), respectively.

To whom correspondence should be addressed: Tel.: 33-99-54-37-37; Fax: 33-99-54-01-37.

(^1)
The abbreviationa used are: PHT, partial hepatectomy; HGF, hepatocyte growth factor; TGF-alpha, transforming growth factor-alpha; pyr, pyruvate; EGF, epidermal growth factor; R point, restriction point; cdk, cyclin-dependent kinase; TBS, Tris-buffered saline; cdc2, cell division cycle mutant 2; FCS, fetal calf serum.


ACKNOWLEDGEMENTS

We express all our thanks to Dr. L. Meijer for his helpful suggestions. We also thank Drs. J. M. Daniel and A. Guillouzo for critical reading of the manuscript.


REFERENCES

  1. Ajchenbaum, F., Ando, K, DeCaprio, J. A., and Griffin, J. D. (1993) J. Biol. Chem. 268, 4113-4119 [Abstract/Free Full Text]
  2. Albrecht, J. H., Hu, M. Y., and Cerra, F. B. (1995) Biochem. Biophys. Res. Commun. 209, 2, 648-655
  3. Andrews, G. K., Dziadek, M., and Tamaoki, T. (1982) J. Biol. Chem. 257, 5148-5153 [Abstract/Free Full Text]
  4. Azzi, L., Meijer, L., Reed, S., Pidikiti, R., and Tung, H. Y. (1992) Eur. J. Biochem. 203, 353-360 [Abstract]
  5. Baldin V., Likas, J., Marcotte, M. J., Pagano, M., Bartek, J., and Draetta, G. (1993) Genes & Dev. 7, 812-821
  6. Battey, J., Moulding, C., Taub, R., Murphy, W., Stewart, T., Potter, H., Lenoir, G., and Leder, P. (1983) Cell 34, 779-787 [Medline] [Order article via Infotrieve]
  7. Campisi, J., Medrano, E. E., Morreo, G., and Pardee, A. B. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 436-440 [Abstract]
  8. Caron de Fromentel, C., May-Levin, F., Mouriesse, H., Lemerle, J., Chandrasekaran, K., and May, P. (1987) Int. J. Cancer 39, 185-189 [Medline] [Order article via Infotrieve]
  9. Chang, E. H., Gonda, M. A., Ellis, R. W., Scolnick, E. M., and Lowy D. R. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 4848-4852 [Abstract]
  10. Corcos, D., Vaulont, S., Denis, N., Lyonnet, S., Simon, M. P., Kitsis, A., Kahn A., and Kruh, J. (1987) Oncogene Res. 1, 60-65
  11. Corral, M., Tichonicky, L., Guguen-Guillouzo, C., Corcos, D., Raymondjean, M., Paris, B., Kruh, J., and Defer, N. (1985) Exp. Cell Res. 160, 427-434 [Medline] [Order article via Infotrieve]
  12. Croy, R., and Pardee, A. B. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 4699-4703 [Abstract]
  13. Dulic, V., Lees, E., and Reed, S. I. (1992) Science 257, 1958-1961 [Medline] [Order article via Infotrieve]
  14. Etienne, P. L., Baffet, G., Desvergne, B., Boisnard-Rissel, M., Glaise, D., and Guguen-Guillouzo, C. (1988) Oncogene Res. 3, 255-262 [Medline] [Order article via Infotrieve]
  15. Fabrikant, J. I. (1968) J. Cell Biol. 36, 551-565 [Abstract/Free Full Text]
  16. Fausto, N. (1992) in Liver Regeneration (Bernuau, D., and Feldman, G., eds) pp. 1-6, John Libbey Eurotext, Paris
  17. Guguen, C., Guillouzo, A., Boisnard, M., Le Cam, A., and Bourel, M. (1975) Biol. Gastroenterol. 8, 223-231
  18. Guguen-Guillouzo, C., and Guillouzo, A. (1983) Mol. Cell. Biochem. 53, 35-56
  19. Higgins, G. M., and Anderson, R. M. (1931) Arch. Pathol. 12, 186-202
  20. Hirai, S. I., Ryseck, R. P., Mechta, F., Bravo, R., and Yaniv M. (1989) EMBO J. 8, 1433-1439 [Abstract]
  21. Ikeda, T., Sawada, N., Fujinaga, K., Minase, T., and Mori, M. (1989) Exp. Cell Res. 185, 292-296 [Medline] [Order article via Infotrieve]
  22. Kato, J.-Y., and Sherr, C. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11513-11517 [Abstract]
  23. Koff, A., Cross, F., Fisher, A., Schumacher, J., Leguellec, K., Philippe, M., and Roberts J. M. (1991) Cell 66, 1212-1221
  24. Lindroos, P. M., Zarnegar, R., and Michalopoulos, G. (1991) Hepatology 13, 743-750 [Medline] [Order article via Infotrieve]
  25. Liu, M.-L., Mars W. M., Zarnegar, R., and Michalopoulos G. K. (1994) Hepatology 19, 1521-1527 [CrossRef][Medline] [Order article via Infotrieve]
  26. Loyer, P., Glaise, D., Cariou, S., Baffet, G., Meijer, L., and Guguen-Guillouzo, C. (1994) J. Biol. Chem. 269, 2491-2500 [Abstract/Free Full Text]
  27. Lu, X. P., Koch, K. S., Lew, D. J., Dulic, V., Pines, J., Reed, S. I., Hunter, T., and Leffert, H. L. (1992) J. Biol. Chem. 267, 2841-2844 [Abstract/Free Full Text]
  28. Matsushime, H., Roussel, M. F., Ashmun, R. A., and Sherr, C. J. (1991) Cell 65, 701-713 [Medline] [Order article via Infotrieve]
  29. McGowan, J. A. (1986) in Isolated and Cultured Hepatocytes (Guillouzo, A., and Guguen-Guillouzo, C., eds) pp. 13-40, INSERM, John Libbey Eurotext, Paris
  30. Mead, J. E., and Fausto, N. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 1558-1562 [Abstract]
  31. Meyerson M., and Harlow E. (1994) Mol. Cell. Biol. 14, 2077-2086 [Abstract]
  32. Michalopoulos, G. (1990) FASEB J. 4, 176-187 [Abstract/Free Full Text]
  33. Morello, D., Lavenu, A., and Babinet, C. (1990) Oncogene 5, 1511-1519 [Medline] [Order article via Infotrieve]
  34. Mullhaupt, B., Feren, A., Fodor, E., and Jones, A. (1994) J. Biol. Chem. 269, 19667-19670 [Abstract/Free Full Text]
  35. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G. (1992) EMBO J. 3, 961-971 [Abstract]
  36. Pardee, A. B. (1992) Curr. Opin. Cell Biol. 4, 141-143
  37. Pledger, W. J., Stiles, C. D., Antoniades, H. N., and Scher, C. D. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 4481-4485 [Abstract]
  38. Pledger, W. J., Stiles, C. D., Antoniades, H. N., and Scher, C. D. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 2839-2843 [Abstract]
  39. Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J., Bar-Sagi, D., Roussel, M. F., and Sherr, C. J. (1993) Genes & Dev. 7, 1559-1571
  40. Raymondjean, M., Kneip, B., and Kruh, J. (1983) Biochim. Biophys. Acta 741, 30-37 [Medline] [Order article via Infotrieve]
  41. Reed, S. I. (1992) Annu. Rev. Cell Biol. 8, 529-561 [CrossRef]
  42. Sargent, T. D., Wu, J. R., Sala-Trepat, J. M., Wallace, R. B., Reyes, A. A., and Bonner, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 3256-3260 [Abstract]
  43. Sawada, N. (1989) Exp. Cell Res. 181, 584-588 [Medline] [Order article via Infotrieve]
  44. Sherr, C. J. (1993) Cell 73, 1059-1065 [Medline] [Order article via Infotrieve]
  45. Sherr, C. J. (1994) Cell 79, 551-555 [Medline] [Order article via Infotrieve]
  46. Sobczack, J., Mechti, N., Tounier, M. F., Blanchard, J. M., and Duguet, M. (1989) Oncogene 4, 1503-1508 [Medline] [Order article via Infotrieve]
  47. Thomas, P. S. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 5201-5205 [Abstract]
  48. Thompson, N. L., Mead, J. E., Braun, L., Goyette, M., Shank, P. R., and Fausto, N. (1986) Cancer Res. 46, 3111-3117 [Abstract]
  49. Tushinski, R., and Stanley, E. R. (1985) J. Cell. Physiol. 122, 221-228 [Medline] [Order article via Infotrieve]
  50. Wang, J., Chenivesse, X., Henglein, B., and Brechot, C. (1990) Nature 343, 555-557 [CrossRef][Medline] [Order article via Infotrieve]
  51. Xiong, Y., Zhang, H., and Beach, D. (1992) Cell 71, 505-514 [Medline] [Order article via Infotrieve]
  52. Yen, A., and Pardee, A. B. (1978) Exp. Cell Res. 116, 103-113 [Medline] [Order article via Infotrieve]
  53. Zettenberg, A., and Larsson, O. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 5365-5369 [Abstract]
  54. Zindy, F., Lamas, E., Chenivesse, X., Sobczack, J., Wang, J., Fresquet, D., Henglein, B., and Brechot, C. (1992) Biochem. Biophys. Res. Commun. 182, 1144-1154 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.